Relmada Therapeutics Stock Forecast - Rate Of Daily Change

RLMD Stock  USD 0.37  0.05  11.90%   
Relmada Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Relmada Therapeutics stock prices and determine the direction of Relmada Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Relmada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Asset Turnover is expected to grow to 0.52, whereas Inventory Turnover is forecasted to decline to 0.0001. . The current year's Common Stock Shares Outstanding is expected to grow to about 31.6 M, whereas Net Loss is forecasted to decline to (148.4 M).
On December 6, 2024 Relmada Therapeutics had Rate Of Daily Change of 1.0. Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Relmada Therapeutics.
Check Relmada Therapeutics VolatilityBacktest Relmada TherapeuticsTrend Details  

Relmada Therapeutics Trading Date Momentum

On December 09 2024 Relmada Therapeutics was traded for  0.48  at the closing time. The top price for the day was 0.51  and the lowest listed price was  0.46 . The trading volume for the day was 2.5 M. The trading history from December 9, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 4.35% . The trading delta at closing time against the current closing price is 0.00% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Relmada Therapeutics to competition

Other Forecasting Options for Relmada Therapeutics

For every potential investor in Relmada, whether a beginner or expert, Relmada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Relmada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Relmada. Basic forecasting techniques help filter out the noise by identifying Relmada Therapeutics' price trends.

View Relmada Therapeutics Related Equities

 Risk & Return  Correlation

Relmada Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Relmada Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Relmada Therapeutics' current price.

Relmada Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Relmada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relmada Therapeutics shares will generate the highest return on investment. By undertsting and applying Relmada Therapeutics stock market strength indicators, traders can identify Relmada Therapeutics entry and exit signals to maximize returns.

Relmada Therapeutics Risk Indicators

The analysis of Relmada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Relmada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting relmada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Relmada Therapeutics is a strong investment it is important to analyze Relmada Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Relmada Therapeutics' future performance. For an informed investment choice regarding Relmada Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections.
For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relmada Therapeutics. If investors know Relmada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relmada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.86)
Return On Assets
(0.59)
Return On Equity
(1.00)
The market value of Relmada Therapeutics is measured differently than its book value, which is the value of Relmada that is recorded on the company's balance sheet. Investors also form their own opinion of Relmada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relmada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relmada Therapeutics' market value can be influenced by many factors that don't directly affect Relmada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relmada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relmada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.